Article
Ranbaxy is launching its isotretinoin product for the treatment of acne, Absorica, in the United States.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
GLP-1 Therapy Offers Dual Benefits for Skin and Heart
Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine
New Antiaging Senotherapeutics: Senolytics and Senomorphics
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
New Guidance Aims to Improve Genital Psoriasis Treatment
IL-23 and IL-17 Inhibitors Reduce Cardiovascular Outcomes in Statin-Treated Psoriasis Patients
FDA Approves Sun Pharma's New LED BLU-U Device for AK
Daily Derm Times: May 15, 2025